Uipath, Inc. (PATH) Stock Price & Analysis
Uipath, Inc. (PATH) rose 6.27% to USD 10.84 as of July 25, 2026 at 01:45 UTC, according to Nexqual real-time market data.
PATH last closed at USD 10.2; the session ranged USD 10.28–10.99 on volume of 63,724,886 shares. Market capitalization is $5.62B, with a 52-week range of USD 9.2–19.84 (NYQ). Source: Nexqual, July 25, 2026 at 01:45 UTC.
Key Statistics (as of July 25, 2026 at 01:45 UTC)
| Price | USD 10.84 |
|---|---|
| Change | ▲ 6.27% (up) |
| Previous Close | USD 10.2 |
| Open | USD 10.27 |
| Day Range | USD 10.28 – 10.99 |
| 52-Week Range | USD 9.2 – 19.84 |
| Volume | 63,724,886 shares |
| Market Cap | $5.62B |
| Exchange | NYQ |
Technical Analysis (PATH)
Nexqual's technical model rates PATH "SELL" based on 1 bullish and 4 bearish signals across 125 daily candles, as of July 25, 2026 at 01:45 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.43 (neutral) |
| vs SMA50 | Below (USD 11.08) |
| MACD | 0.04 (positive) |
Analyst Ratings (PATH)
Wall Street analysts rate PATH "None" based on 16 analysts, with a mean price target of USD 13.25 (range USD 10.98–17), per Nexqual as of July 25, 2026 at 01:45 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 16 |
| Mean Target | USD 13.25 |
| High Target | USD 17 |
| Low Target | USD 10.98 |
| Buy / Hold / Sell | 3 / 16 / 1 |
Earnings (PATH)
| Next Earnings Date | 2026-09-03 |
|---|---|
| EPS Estimate | USD 0.15 |
| Revenue Estimate | $397.85M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-04-30 | USD 0.15 vs est 0.16 ▼ miss |
| 2026-01-31 | USD 0.3 vs est 0.25 ▲ beat |
| 2025-10-31 | USD 0.16 vs est 0.15 ▲ beat |
| 2025-07-31 | USD 0.15 vs est 0.08 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financials & Fundamentals (PATH)
| Total Revenue | $1.67B |
|---|---|
| Revenue Growth (YoY) | +17.30% |
| Gross Margin | +83.05% |
| Operating Margin | +7.27% |
| Profit Margin | +19.58% |
| ROE | +18.18% |
| Debt / Equity | 4.36 |
| Current Ratio | 2.31 |
| Total Cash | $1.31B |
| Total Debt | $83.00M |
| Free Cash Flow | $511.55M |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Financial Health Score (PATH)
Nexqual rates Uipath, Inc.'s overall financial health "Strong" across five dimensions, as of July 25, 2026 at 01:45 UTC.
| Growth | Solid — Revenue +13% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 83%, operating 7% |
| Balance Sheet | Strong — $1.31B cash vs $83M debt, net cash position |
| Cash Flow | Strong — FCF $512M, 32% margin |
| Efficiency | Solid — ROE 18%, ROA 2.4% |
Ownership (PATH)
| Insider Ownership | +9.55% |
|---|---|
| Institutional Ownership | +83.37% |
| Shares Outstanding | 453.43M |
| Float | 410.04M |
| Short % of Float | +34.57% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
Leadership (PATH)
Uipath, Inc. is led by Daniel Solomon Dines (age 53), Co-Founder, CEO, & Executive Chairman of the Board, per Nexqual as of July 25, 2026 at 01:45 UTC.
| Co-Founder, CEO, & Executive Chairman of the Board | Daniel Solomon Dines (age 53) |
|---|---|
| CFO & COO | Ashim Gupta (age 46) |
| Deputy CFO & Chief Accounting Officer | Hitesh Ramani |
| Chief Product & Technology Officer | Raghavendra Malpani (age 47) |
| Senior Director of Investor Relations | Allise Furlani |
Major Backers & Investors (PATH)
Notable institutional backers of Uipath, Inc. include Tetragon Partners GP Ltd., Bank of America Corporation, UBS Group AG, according to Nexqual as of July 25, 2026 at 01:45 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Tetragon Partners GP Ltd. | 5.56% |
| Bank of America Corporation | 2.22% |
| UBS Group AG | 2.07% |
| Morgan Stanley | 1.88% |
| Senvest Management LLC | 1.72% |
| Federated Hermes Equity Funds-Federated Hermes MDT Mid Cap Growth Fund | 0.84% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 19.42% |
| BlackRock | 13.25% |
| State Street | 3.66% |
| Geode Capital | 1.78% |
Source: Nexqual, July 25, 2026 at 01:45 UTC.
From Uipath, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)
Key Strengths & Strategy (as disclosed to the SEC)
- Our platform empowers customers to combine automation, AI agents, and people, delivering end-to-end process orchestration that drives innovation.
- We host and present regularly at regional and global events, including our own Fusion and On Tour conferences, and Summit and DevCon events.
- We rely on a combination of patent, copyright, trademark, and trade secret laws in the U.S. and other jurisdictions, as well as license agreements, confidentiality procedures, non-disclosure agreements with third parties, and other contractual protections, to protect our intellectual property rights, including our proprietary technology, software, know-how, and brand.
- Although we rely on intellectual property rights, including patents, copyrights, trademarks, and trade secrets, as well as contractual protections to establish and protect our proprietary rights, we believe that factors such as the technological and creative skills of our personnel, development of new services, features, and functionality, and frequent enhancements to our platform are equally essential to establishing and maintaining our technology leadership position.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AI | C3.ai, Inc. | USD 8.15 | ▼ 0.49% |
| UPST | Upstart Holdings, Inc. | USD 26.93 | ▼ 5.97% |
| U | Unity Software Inc. | USD 28.62 | ▼ 2.22% |
| SOUN | SoundHound AI, Inc. | USD 6.16 | ▼ 4.64% |
| SNOW | Snowflake Inc. | USD 268.06 | ▲ 0.1% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:45 UTC. This page is informational and not investment advice.